Morepen Laboratories Limited — Updates, 26-05-2026: Amendment(s)

Morepen Labs' board approved financial results and proposed a final dividend of ₹0.20/share. A revised Business Transfer Agreement for Medical Devices business slump sale to its subsidiary was approved for ₹197.10 Cr due to licensing delays.